KRYS Financials
Krystal Biotech Inc - Financial statements & key metrics
Stock Price
$270.00
Market Cap
$7.87B
P/E Ratio
39.0
EPS
$6.85
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$290.51M
Gross Profit
-
Operating Income
-
Net Income
$89.16M
EPS (Diluted)
$3.00
Balance Sheet Highlights
Total Assets
$1.06B
Total Liabilities
$109.46M
Shareholders Equity
-
Cash & Equivalents
$344.87M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$123.42M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
94.1%
Operating Margin
0.4%
Net Margin
0.5%
ROE
0.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is KRYS revenue?
KRYS's most recent quarterly revenue was $290.51M. Annual revenue can be calculated by summing the four most recent quarters.
Is KRYS profitable?
KRYS reported a profit of $89.16M in the most recent quarter. The net profit margin is 0.5%.
What is KRYS market cap?
KRYS has a market capitalization of $7.87B, making it a mid-cap stock.
Does KRYS have debt?
View KRYS's balance sheet for debt information.
What is KRYS cash flow?
Cash flow data is available in the full financial statements.